These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15699173)

  • 1. In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.
    Bonyhadi M; Frohlich M; Rasmussen A; Ferrand C; Grosmaire L; Robinet E; Leis J; Maziarz RT; Tiberghien P; Berenson RJ
    J Immunol; 2005 Feb; 174(4):2366-75. PubMed ID: 15699173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies.
    Bohlen H; Hopff T; Manzke O; Engert A; Kube D; Wickramanayake PD; Diehl V; Tesch H
    Blood; 1993 Sep; 82(6):1803-12. PubMed ID: 7691238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CD3/CD28 bead-activated and expanded T cells on leukemic B cells in chronic lymphocytic leukemia.
    Patten P; Devereux S; Buggins A; Bonyhadi M; Frohlich M; Berenson RJ
    J Immunol; 2005 Jun; 174(11):6562-3; author reply 6563. PubMed ID: 15905490
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of CD3/CD28 bead-activated T cells on leukemic B cells in chronic lymphocytic leukemia.
    Prieto A; Sanchez M; Perucha E; Alvarez-Mon M
    J Immunol; 2005 Aug; 175(4):2042-3. PubMed ID: 16081767
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
    Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
    Johnson-Léger C; Christensen J; Klaus GG
    Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-costimulated T cells-phase I clinical trial.
    Lum LG; LeFever AV; Treisman JS; Garlie NK; Hanson JP
    J Immunother; 2001; 24(5):408-19. PubMed ID: 11696696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
    Ranheim EA; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):925-35. PubMed ID: 7681471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.
    Kalamasz D; Long SA; Taniguchi R; Buckner JH; Berenson RJ; Bonyhadi M
    J Immunother; 2004; 27(5):405-18. PubMed ID: 15314550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
    Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
    Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells.
    Stock S; Hoffmann JM; Schubert ML; Wang L; Wang S; Gong W; Neuber B; Gern U; Schmitt A; Müller-Tidow C; Dreger P; Schmitt M; Sellner L
    Hum Gene Ther; 2018 Oct; 29(10):1167-1182. PubMed ID: 30024314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
    Li Q; Grover AC; Donald EJ; Carr A; Yu J; Whitfield J; Nelson M; Takeshita N; Chang AE
    J Immunol; 2005 Aug; 175(3):1424-32. PubMed ID: 16034078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrovirus-mediated gene transfer in human primary T lymphocytes induces an activation- and transduction/selection-dependent TCR-B variable chain repertoire skewing of gene-modified cells.
    Coito S; Sauce D; Duperrier A; Certoux JM; Bonyhadi M; Collette A; Kuehlcke K; Hervé P; Tiberghien P; Robinet E; Ferrand C
    Stem Cells Dev; 2004 Feb; 13(1):71-81. PubMed ID: 15068695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.
    Schuler M; Tretter T; Schneller F; Huber C; Peschel C
    Immunobiology; 1999 Feb; 200(1):128-39. PubMed ID: 10084701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
    Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
    Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis.
    Walsh PT; O'Connor R
    Eur J Immunol; 2000 Apr; 30(4):1010-8. PubMed ID: 10760788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern.
    Rezvany MR; Jeddi-Tehrani M; Biberfeld P; Söderlund J; Mellstedt H; Osterborg A; Rabbani H
    Br J Haematol; 2001 Nov; 115(2):263-71. PubMed ID: 11703320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 costimulation induces delta opioid receptor expression during anti-CD3 activation of T cells.
    Nguyen K; Miller BC
    J Immunol; 2002 May; 168(9):4440-5. PubMed ID: 11970987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.